STABILITY OF ADRIAMYCIN-INDUCED DNA-ADDUCTS AND INTERSTRAND CROSS-LINKS

被引:51
作者
VANROSMALEN, A [1 ]
CULLINANE, C [1 ]
CUTTS, SM [1 ]
PHILLIPS, DR [1 ]
机构
[1] LA TROBE UNIV,SCH BIOCHEM,BUNDOORA,VIC 3083,AUSTRALIA
基金
澳大利亚研究理事会;
关键词
D O I
10.1093/nar/23.1.42
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The stability of adriamycin-induced DNA adducts and interstrand crosslinks was measured at 37 degrees C by three independent procedures. The loss of [C-14]-labelled adducts was described by two first-order decays with half-lives of 7.4 h (60% amplitude) and 39 h (40%). The loss of the drug chromophore also exhibited a biphasic character, with half-lives of 6 h (65%) and similar to 150 h (35%). The decay of transcriptional blockages at an isolated, apparent interstrand GpC crosslinking site was described by two first-order processes, with half-lives of 3 h (65%) and 40 h (35%), whereas the decay of transcriptional blockages at an isolated guanine residue (apparent site of monoadduct) was completely described by a first-order decay with a half-life of 5.3 h. The loss of interstrand crosslinks was measured using a gel electrophoresis assay, and the decay was characterised by a single first-order process with a half-life of 4.7 h. Collectively, these values serve to define a model of the interstrand crosslink with unstable sites of attachment at both ends of the crosslink, with half-lives at either end being similar to 5 and 40 h. The adducts exhibited increasing lability with increasing pH, and were particularly unstable at pH 12, with a half-life of similar to 0.5 h. The adducts were also heat labile, with an overall melting temperature of 67 degrees C (10 min exposure) and this was also the thermal lability measured at three individual adduct sites probed by lambda exonuclease.
引用
收藏
页码:42 / 50
页数:9
相关论文
共 42 条
[1]  
BUTLER J, 1987, British Journal of Cancer, V55, P53
[2]   DOES ADRIAMYCIN INDUCE INTERSTRAND CROSS-LINKS IN DNA [J].
CULLINANE, C ;
VANROSMALEN, A ;
PHILLIPS, DR .
BIOCHEMISTRY, 1994, 33 (15) :4632-4638
[3]   INDUCTION OF STABLE TRANSCRIPTIONAL BLOCKAGE SITES BY ADRIAMYCIN - GPC SPECIFICITY OF APPARENT ADRIAMYCIN DNA ADDUCTS AND DEPENDENCE ON IRON(III) IONS [J].
CULLINANE, C ;
PHILLIPS, DR .
BIOCHEMISTRY, 1990, 29 (23) :5638-5646
[4]   THERMAL-STABILITY OF DNA ADDUCTS INDUCED BY CYANOMORPHOLINOADRIAMYCIN INVITRO [J].
CULLINANE, C ;
PHILLIPS, DR .
NUCLEIC ACIDS RESEARCH, 1993, 21 (08) :1857-1862
[5]   FORMATION OF ADRIAMYCIN - DNA-ADDUCTS IN-VITRO [J].
CULLINANE, C ;
CUTTS, SM ;
VANROSMALEN, A ;
PHILLIPS, DR .
NUCLEIC ACIDS RESEARCH, 1994, 22 (12) :2296-2303
[6]   DETERMINATION OF COVALENT BINDING TO INTACT DNA, RNA, AND OLIGONUCLEOTIDES BY INTERCALATING ANTICANCER DRUGS USING HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY - STUDIES WITH DOXORUBICIN AND NADPH CYTOCHROME-P-450 REDUCTASE [J].
CUMMINGS, J ;
BARTOSZEK, A ;
SMYTH, JF .
ANALYTICAL BIOCHEMISTRY, 1991, 194 (01) :146-155
[7]   THE MOLECULAR PHARMACOLOGY OF DOXORUBICIN INVIVO [J].
CUMMINGS, J ;
ANDERSON, L ;
WILLMOTT, N ;
SMYTH, JF .
EUROPEAN JOURNAL OF CANCER, 1991, 27 (05) :532-535
[8]   THE CONSEQUENCES OF DOXORUBICIN QUINONE REDUCTION INVIVO IN TUMOR-TISSUE [J].
CUMMINGS, J ;
WILLMOTT, N ;
HOEY, BM ;
MARLEY, ES ;
SMYTH, JF .
BIOCHEMICAL PHARMACOLOGY, 1992, 44 (11) :2165-2174
[9]   TRANSFER OF FERRITIN-BOUND IRON TO ADRIAMYCIN [J].
DEMANT, EJF .
FEBS LETTERS, 1984, 176 (01) :97-100
[10]  
DEVITA VT, 1993, CANCER PRINCIPLES PR, V1